Digest Network Come funziona
Network
/
Società
Al
Non verificato

Alkermes plc

Di cosa scriviamo

BiotecnologiaFarmaceuticaPsichiatriaSaluteSanità

55 comunicati stampa

Guarda tutti i comunicati
28/07/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Psichiatria
Alkermes plc Reports Second Quarter 2026 Financial Results
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
14/07/2026
Biotecnologia
Sanità
Psichiatria
Salute
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Alkermes to Report Second Quarter Financial Results on July 28, 2026
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
13/07/2026
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Industria
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
17/06/2026
Eventi
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
15/06/2026
Industria
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
04/06/2026
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Psichiatria
Medicina - Varie
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
03/06/2026
Biotecnologia
Farmaceutica
Finanza
Salute
Psichiatria
Associazioni/Professionisti
Medicina - Varie
Eventi
Web e Social Network
Alkermes to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
26/05/2026
Eventi
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
21/05/2026
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Psichiatria
Medicina - Varie
Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0
12/05/2026
Industria
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia
Fonte
Alkermes plc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0